Now the EUCAST posters at ECCMID 2015 are available.
The new agents dalbavancin, oritavancin and tedizolid have been approved
We have added a clarification about "conflicts of interest" of
Find the updated version (and previous versions) on the FAQ website.
Dr. William A. Craig, Bill to those of us who knew him and benefited from
Between the 28th of February and the 12th of March Gunnar Kahlmeter and
The Agenda for the 2015 EUCAST General Committee (Copenhagen, Denmark)